Clinical trial of tolerability, safety and immunogenicity of influenza inactivated split-vaccine Flu-M in children aged 6 to 17 years
Purpose. To evaluate the tolerability, safety and immunogenicity of influenza inactivated split flu vaccine Flu-M during single immunization of children aged 6 to 17 years.Materials and methods. A multicentre double-blind comparative randomised clinical trial of influenza inactivated split vaccine F...
Saved in:
| Main Authors: | A. M. Korolyuk, V. N. Kraeva, L. A. Zazimko, Yu. A. Koromzin, E. A. Ruzanova, N. N. Savina, E. V. Ryskova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2024-04-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1605 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical trial of tolerability, safety, and immunogenicity of the Russian influenza inactivated split vaccine Flu-m in children from 6 months to 9 years of age
by: A. M. Korolyuk, et al.
Published: (2023-10-01) -
Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
by: I. V. Fel'dblyum, et al.
Published: (2018-02-01) -
Evaluation of the Epidemiological Effectiveness of a Quadrivalent Inactivated Split Influenza Vaccine in the 2023–2024 flu season
by: R. V. Polibin, et al.
Published: (2025-01-01) -
The Impact Annual Immunization against Flu on Morbidity of Flu in the Russian Federation
by: A. Yu. Popova, et al.
Published: (2016-02-01) -
Solved and Problematic Issues of Influenza epidemiology one hundred years after Spanish Flu Pandemic
by: A. B. Belov, et al.
Published: (2019-11-01)